News
Glaucoma UK and the Royal College of Ophthalmologists announce the 2024 research award winners
Glaucoma UK and the Royal College of Ophthalmologists are delighted to announce the winners of the 2024 Glaucoma UK/RCOphth Research Award. As a result of the high quality of applications received, the judging panel have awarded two projects, worth nearly...
ABDO announces groundbreaking therapy for contact lens opticians
The Association of British Dispensing Opticians (ABDO) has given the go ahead for contact lens opticians to prescribe a groundbreaking new therapy, enabling ~1,700 new practitioners to offer the treatment to their patients. NuVision Biotherapies, a UK based tissue-therapy company...
HOYA Vision Care’s Defocus Incorporated Multiple Segments Spectacle Lenses demonstrated significant trend of myopia control in children
Interim analysis from the Observational French Study in children presented at EPOS 2024 meeting in Paris. Data from an interim analysis of the Observational French Study, OPHTAMYOP, has demonstrated a significant trend of myopia control in children with spherical equivalent...
New study uncovers key mechanism behind a common genetic cause of age-related visual loss
A groundbreaking study has revealed important insights into the mechanisms behind Fuchs Endothelial Corneal Dystrophy (FECD), a common cause of age-related visual loss, providing hope for future therapeutic developments, and finding implications for other neurological diseases. FECD is a common,...
MicroPulse Transscleral Laser Therapy: A Prospective UK Study
Register now to participate. Eagerly anticipated and now underway – a landmark UK medical research study on MicroPulse® Transscleral Laser Therapy (MPTLT) for the treatment of glaucoma using Iridex’ Cyclo G6® Laser and the MicroPulse P3® Delivery Device. A NICE-compliant...
Biomarkers reveal how patients with glaucoma may respond to treatment
Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers at UCL and Moorfields Eye Hospital.
Boosting key protein in eye cells could prevent age-related vision loss, international team finds
Increasing the levels of a key protein in the cells at the back of the eye could help protect against the leading cause of vision loss among older adults, finds a new discovery made by researchers from the UK, US, Germany and Australia.
New study maps priorities for UK eyecare research
Glaucoma, age-related macular degeneration, childhood vision loss, and short-sightedness are highlighted as target study areas.
Innovative 3D printing could revolutionise treatment for cataracts and other eye conditions
University of East Anglia researchers have made a significant breakthrough in ocular device technology with the introduction of a novel resin for 3D printing intraocular devices. This innovation has potential to enhance the manufacture of eye implants universally used in cataract and refractive surgeries.
Glaucoma UK announces United Kingdom & Eire Glaucoma Society (UKEGS) Research Award 2024
Glaucoma UK is delighted to announce that this year’s UKEGS Research Award is now open to UKEGS members. The award, funded by Glaucoma UK and UKEGS, offers up to £50,000 for projects aimed at impacting patient care, scientific advancement, or understanding of glaucoma.
OKKO Health announce collaboration with the University of Plymouth to measure vision in extreme environments including space
OKKO Health, a leader in innovative eye health technology, is excited to announce its collaboration with the University of Plymouth. This groundbreaking project will test eye health and track early disease detection in extreme environments, beginning with the depths of a cave and soon to monitor astronauts’ vision in the vastness of space.
Glaucoma UK offers up to £50,000 for the Open Call Research Award 2024
Glaucoma UK accepts applications for the Open Call Research Award 2024, which offers up to £50,000 in funding for glaucoma-related research. This award invites both clinical and non-clinical researchers who aim to enhance our understanding of glaucoma, and improve outcomes for people living with the disease.
